 |
Recent News
ATryn* (antithrombin alfa) BLA Filing Accepted By FDA
October 06, 2008
OVATION Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ATryn*.
OVATION Pharmaceuticals Acquires Rights To Commercialize Xenazine® In U.S. For Chorea Associated With Huntington's Disease
October 01, 2008
OVATION Pharmaceuticals, Inc. announced today that it has acquired from Prestwick Pharmaceuticals the exclusive license in the United States to commercialize Xenazine®.
iBIO President’s - President's Letter – September 2008
September 30, 2008
Before the Fall (Disappears)
More iBIO News
|
 |
Upcoming Events
BioExec Institute
10/08/2008 – 12/09/2008
Berkeley, CA
Encyclopedia of Life (EOL): Integrating Biodiversity and Information Technology
10/14/2008
Chicago, IL
More Upcoming Events
Leadership Sponsors
 |